The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...
A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.
AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.
AbbVie loses bid to block Tennessee 340B law as federal court upholds state statute limiting drugmaker restrictions on contract pharmacies.
A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B savings within a single state. | A Minnesota analysis of providers' reported ...
MedPage Today on MSN
Hospitals, drugmakers, and US government continue battle over 340B program
The drug discount program is under scrutiny on a variety of fronts ...
The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.
On July 31, 2025, the U.S. Department of Health and Human Services (HHS) announced that it will conduct a pilot program testing out a rebate model for 340B drug purchases. Under the program, drug ...
On July 31, 2025, notice was published in the Federal Register by the Health Resources and Services Administration (“HRSA”) of a “340B Rebate Model Pilot Program” (“340B Pilot Program”). The 340B ...
When it was passed in 1992, no one thought to mandate how hospitals and clinics would spend the deep discounts they receive on prescription drugs.
Letter: Protecting rural health care: why the 340B program is more important than big PhRMA profits.
Disappointed, but not surprised. That was my reaction to the news that two more pharmaceutical groups are suing the state of North Dakota over a new law designed to protect the 340B Drug Pricing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results